A bioinformatics analysis of glioma cohort data showed that HK-II overexpression in gliomas was prognostic with the up-regulation of already known associated markers with tumor progression/recurrence (such as VEGF, CXCL8, and HIF1A). This evidence concerns the gene VEGFA and central nervous system cancer.